Latest News - Neuromuscular

Wednesday, February 07, 2018 | Neuromuscular

Results from Phase 2 Trial of Stem-Cell Treatment for Amyotrophic Lateral Sclerosis to Be Presented at American Academy of Neurology 2018

Brainstorm Cell Therapeutics Inc. announced that they will present results from the NurOwn phase 2 randomized, double-blind, placebo-controlled study, showing ALSFRS-R subgroup analyses and micro-RNA …

Read the full story

Tuesday, January 09, 2018 | FDA Approval/Clearance, Neuromuscular

Sublingual Formulation of Riluzole Bioequivalent to Tablet Formulation

Biohaven announced positive results from its bioequivalence study of BHV-0223, an innovative sublingual formulation of riluzole, currently available as a 50-mg tablet, which is currently the standard-…

Read the full story